Get notified when FENC files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsFennec Pharmaceuticals announces four PEDMARK abstracts accepted at 2026 ASCO conference
Filed April 22, 2026 · Period ending April 22, 2026 · ~1 min read
Key Changes
-
low
Four research abstracts evaluating PEDMARK (sodium thiosulfate injection) accepted for presentation or publication at the American Society of Clinical Oncology Annual Meeting in Chicago, scheduled for 2026.
Item 8.01 verify on EDGAR → -
low
Press release issued April 21, 2026, announcing the ASCO abstract acceptances, providing visibility for the company's product at a major oncology conference.
Exhibit 99.1 view on EDGAR →
This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (CAG 10-K) is open in full — no account needed.
Partner
Trade FENC commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jun 2, 2026 · How we verify